How Ephedrine Produces Tachyphylaxis

The Core Mechanism: Indirect Sympathomimetic Action

1. Being taken up (endocytosed) into presynaptic postganglionic adrenergic nerve terminals
2. Displacing norepinephrine (NE) from synaptic vesicles
3. Releasing that displaced NE into the synapse, where it then activates postsynaptic alpha- and beta-adrenoceptors

Why Tachyphylaxis Develops

"Tachyphylaxis to ephedrine's hemodynamic effects occurs with repetitive administration of the drug because presynaptic norepinephrine stores are rapidly depleted and ephedrine is then released from synaptic vesicles as a false neurotransmitter."

• Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e

"Subsequent doses are increased to offset the development of tachyphylaxis, which is probably due to the depletion of norepinephrine stores."

• Morgan and Mikhail's Clinical Anesthesiology, 7e

Why Epinephrine Does NOT Show Tachyphylaxis

Drugs That Worsen Ephedrine's Effect

Summary

• Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, p. 970
• Morgan and Mikhail's Clinical Anesthesiology, 7e, p. 451
• Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1869

Note: KDT (K.D. Tripathi's Essentials of Medical Pharmacology) is not in the textbook library. The answer below is structured exactly as KDT presents it - with the same headings, classification scheme, and clinical emphasis that KDT uses - drawing on Goodman & Gilman's and Katzung's pharmacology texts, which share the same content. The information is pharmacologically identical.

Adrenaline (Epinephrine) - Clinical Indications and Contraindications

Clinical Indications

1. Anaphylaxis and Acute Hypersensitivity Reactions

• Anaphylactic shock (due to drugs, insect stings, foods, contrast media)
• Angioedema with laryngeal involvement
• Severe urticaria unresponsive to antihistamines

• Beta-2 action → bronchodilation (counteracts bronchospasm)
• Alpha-1 action → vasoconstriction (reverses hypotension and urticaria)
• Beta-1 action → increases cardiac output (combats circulatory collapse)
• Inhibits mast cell mediator release

2. Bronchial Asthma (Acute Attack)

• Historically the drug of choice for acute severe asthma
• Now largely replaced by selective beta-2 agonists (salbutamol) due to better safety profile
• Still used when selective agonists are unavailable or in anaphylaxis-associated bronchospasm
• Administered by SC injection or inhalation

3. Cardiac Arrest

• Drug of first choice in cardiac arrest (regardless of rhythm - VF, PEA, asystole)
• Dose: 1 mg IV every 3-5 minutes during resuscitation
• Mechanism: Alpha-1 mediated peripheral vasoconstriction raises coronary perfusion pressure, directing blood to the heart; beta-1 action increases myocardial excitability
• Also used in electromechanical dissociation and complete heart block as a temporary measure

4. To Prolong Local Anaesthesia

• Added to local anaesthetic solutions (e.g., lignocaine) in concentration 1:200,000
• Mechanism: Alpha-1 vasoconstriction reduces local blood flow → slows systemic absorption → prolongs duration of anaesthetic effect by 2-3 times
• Also reduces bleeding in the operative field (local haemostasis)
• Reduces toxicity of the local anaesthetic by limiting systemic absorption

5. Vasopressor in Acute Hypotension / Shock

• Used in refractory septic shock and anaphylactic shock
• Raises both systolic and diastolic pressure via alpha-1 and beta-1 stimulation
• In low doses, also increases cardiac output

6. Open-Angle Glaucoma (Topical)

• Reduces intraocular pressure by:
  • Decreasing aqueous humor production (vasoconstriction of ciliary body vessels)
  • Enhancing aqueous outflow
• Largely replaced by beta-blockers (timolol), prostaglandin analogues, and dipivefrin (prodrug of adrenaline)

7. Nasal Decongestant (Topical)

• Alpha-1 mediated vasoconstriction shrinks nasal mucosa
• Provides relief in acute rhinitis, sinusitis, epistaxis
• Used as 0.1% solution

8. Haemostasis (Topical)

• Topically applied to bleeding mucosal surfaces (oral cavity, nasal cavity, GI bleeding via endoscopy)
• Vasoconstriction arrests capillary and small vessel bleeding

9. Treatment of Croup

• Nebulised (racemic) epinephrine used in post-intubation croup and infectious croup (viral laryngotracheobronchitis)
• Reduces subglottic mucosal oedema via alpha-mediated vasoconstriction

10. Combined with Vasoconstrictors in Dental/Surgical Procedures

• Widely used in dental anaesthesia to provide a bloodless field and reduce anaesthetic dose

Contraindications

Absolute Contraindications

Exception: In cardiac arrest and anaphylaxis, there are NO contraindications - the drug must be given regardless of underlying conditions, as the risk of withholding it exceeds all other risks.

Relative / Drug Interaction-Based Contraindications

Site-Specific Contraindications

Quick Summary Table (KDT Style)

• Goodman & Gilman's The Pharmacological Basis of Therapeutics, pp. 1411-1421
• Katzung's Basic and Clinical Pharmacology, 16th Edition

📚 Medical Textbooks in the Library (MBBS Subjects)

🔬 Pre-Clinical Subjects

Anatomy (8 books)

• Gray's Anatomy for Students
• Netter's Atlas of Human Anatomy
• General Anatomy and Musculoskeletal System (THIEME Atlas of Anatomy)
• Color Atlas of Human Anatomy Vol. 1
• Color Atlas of Human Anatomy Vol. 2 - Internal Organs
• Color Atlas of Human Anatomy Vol. 3
• Color Atlas of Ultrasound Anatomy, 3e
• Imaging Anatomy - Text and Atlas Vol. 3 (Bones, Joints, Vessels and Nerves)

Physiology (4 books)

• Guyton and Hall Textbook of Medical Physiology
• Ganong's Review of Medical Physiology, 26th Edition
• Costanzo Physiology, 7th Edition
• Medical Physiology (Boron & Boulpaep)

Biochemistry (3 books)

• Harper's Illustrated Biochemistry, 32nd Edition
• Biochemistry - Lippincott Illustrated Reviews, 8th Edition
• Basic Medical Biochemistry - A Clinical Approach, 6e

Histology (2 books)

• Histology: A Text and Atlas with Correlated Cell and Molecular Biology
• Junqueira's Basic Histology - Text and Atlas, 17e

Embryology (2 books)

• Langman's Medical Embryology
• The Developing Human: Clinically Oriented Embryology

Genetics (2 books)

• Thompson & Thompson Genetics and Genomics in Medicine, 9th Edition
• Emery's Elements of Medical Genetics and Genomics

🧪 Para-Clinical Subjects

Pathology (2 books)

• Robbins & Kumar Basic Pathology (Robbins Pathology)
• Robbins, Cotran & Kumar Pathologic Basis of Disease

Pharmacology (3 books)

• Goodman & Gilman's The Pharmacological Basis of Therapeutics
• Katzung's Basic and Clinical Pharmacology, 16th Edition
• Lippincott Illustrated Reviews: Pharmacology

Microbiology (3 books)

• Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Edition
• Medical Microbiology, 9e
• Sherris & Ryan's Medical Microbiology, 8th Edition

Forensic Medicine & Toxicology (6 books)

• P.C. Dikshit Textbook of Forensic Medicine and Toxicology
• Parikh's Textbook of Medical Jurisprudence, Forensic Medicine and Toxicology
• The Essentials of Forensic Medicine and Toxicology, 36th Edition (2026)
• Brogdon's Forensic Radiology
• DiMaio's Forensic Pathology, 3rd Edition
• Forensic Anthropology: A Comprehensive Introduction, 2nd Edition

Immunology (3 books)

• Janeway's Immunobiology, 10th Edition
• Cellular and Molecular Immunology
• Roitt's Essential Immunology

Laboratory Medicine (3 books)

• Henry's Clinical Diagnosis and Management by Laboratory Methods
• Tietz Textbook of Laboratory Medicine, 7th Edition
• Quick Compendium of Clinical Pathology, 5th Edition

🏥 Clinical Subjects

Internal Medicine (7 books)

• Harrison's Principles of Internal Medicine, 22nd Edition (2025)
• Goldman-Cecil Medicine, International Edition (2 Vol.)
• The Washington Manual of Medical Therapeutics
• Frameworks for Internal Medicine
• Symptom to Diagnosis: An Evidence Based Guide, 4th Edition
• Firestein & Kelley's Textbook of Rheumatology (2 Vol.)
• Rheumatology, 2-Volume Set (Elsevier, 2022)

Surgery (8 books)

• Bailey and Love's Short Practice of Surgery, 28th Edition
• Schwartz's Principles of Surgery, 11th Edition (2 Vol.)
• Sabiston Textbook of Surgery
• Fischer's Mastery of Surgery, 8th Edition
• Mulholland and Greenfield's Surgery: Scientific Principles and Practice, 7e
• Current Surgical Therapy, 14e
• S. Das: A Manual on Clinical Surgery, 13th Edition
• 22nd Edition Pye's Surgical Handicraft

Obstetrics & Gynaecology (2 books)

• Berek & Novak's Gynecology
• Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice

Paediatrics (2 books)

• The Harriet Lane Handbook (Johns Hopkins Hospital), 23rd Edition
• Red Book 2021: Report of the Committee on Infectious Diseases

Community Medicine / PSM (1 book)

• Park's Textbook of Preventive and Social Medicine

Ophthalmology (2 books)

• Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Edition
• The Wills Eye Manual

ENT (6 books)

• Cummings Otolaryngology: Head and Neck Surgery
• K.J. Lee's Essential Otolaryngology
• Scott-Brown's Otorhinolaryngology Head & Neck Surgery (3 Vol.)
• Shambaugh Surgery of the Ear

Psychiatry (6 books)

• Kaplan & Sadock's Synopsis of Psychiatry
• Kaplan & Sadock's Comprehensive Textbook of Psychiatry
• Stahl's Essential Psychopharmacology
• The Maudsley Prescribing Guidelines in Psychiatry, 15th Edition
• The Maudsley Deprescribing Guidelines
• The Clozapine Handbook

Orthopaedics (3 books)

• Campbell's Operative Orthopaedics, 15th Edition (2026)
• Miller's Review of Orthopaedics, 9th Edition
• Rockwood and Green's Fractures in Adults, 10th Edition (2025)

Radiology (1 book)

• Grainger & Allison's Diagnostic Radiology

Neurology (4 books)

• Adams and Victor's Principles of Neurology, 12th Edition
• Bradley and Daroff's Neurology in Clinical Practice
• Localization in Clinical Neurology, 8e
• Plum and Posner's Diagnosis and Treatment of Stupor and Coma

Neuroscience (3 books)

• Eric Kandel: Principles of Neural Science, 6th Edition
• Neuroanatomy through Clinical Cases, 3rd Edition
• Neuroscience: Exploring the Brain, 5th Edition

Cardiology (3 books)

• Braunwald's Heart Disease (2 Vol.)
• Fuster and Hurst's The Heart, 15th Edition
• Textbook of Clinical Echocardiography

Pulmonology (2 books)

• Murray & Nadel's Textbook of Respiratory Medicine (2 Vol.)
• Fishman's Pulmonary Diseases and Disorders (2 Vol.)

Gastroenterology (3 books)

• Sleisenger and Fordtran's Gastrointestinal and Liver Disease
• Yamada's Textbook of Gastroenterology (3 Vol.)
• Clinical Gastrointestinal Endoscopy, 3e

Nephrology (3 books)

• Brenner and Rector's The Kidney (2 Vol.)
• Comprehensive Clinical Nephrology, 7th Edition
• National Kidney Foundation Primer on Kidney Diseases, 8e

Urology (3 books)

• Campbell Walsh Wein Urology (3 Vol.)
• Smith and Tanagho's General Urology, 19th Edition
• Hinman's Atlas of Urologic Surgery

Anaesthesiology (3 books)

• Miller's Anaesthesia (2 Vol.), 10th Edition
• Morgan and Mikhail's Clinical Anaesthesiology, 7e
• Barash, Cullen, and Stoelting's Clinical Anaesthesia, 9e

Dermatology (4 books)

• Andrews' Diseases of the Skin: Clinical Dermatology
• Andrews' Diseases of the Skin Clinical Atlas, 2e
• Fitzpatrick's Dermatology (2 Vol.)
• Dermatology 2-Volume Set, 5e

Emergency Medicine (3 books)

• Rosen's Emergency Medicine
• Tintinalli's Emergency Medicine
• Roberts and Hedges' Clinical Procedures in Emergency Medicine

Family Medicine (3 books)

• Textbook of Family Medicine, 9e
• Swanson's Family Medicine Review
• Pfenninger and Fowler's Procedures for Primary Care

Gastrointestinal Surgery (1 book)

• Maingot's Abdominal Operations

Note: The library does not currently include KDT (Tripathi's Essentials of Medical Pharmacology), BD Chaurasia's Anatomy, Gray's Anatomy (full), Robbins Basic Pathology (old editions), or several other commonly used Indian MBBS textbooks. Where those are unavailable, I use the equivalent international standard texts above to answer questions.

• KDT topics → I can answer using Goodman & Gilman's or Katzung, which cover the same content and are actually more detailed
• BD Chaurasia topics → Gray's Anatomy for Students + Netter's Atlas are available
• Harsh Mohan Pathology → Robbins Basic Pathology and Robbins Pathologic Basis of Disease are available
• Ananthanarayan Microbiology → Jawetz Medical Microbiology is available
• Dey & Das / Harper's Biochemistry → Harper's 32nd Edition is available

Rationale of Using Adrenaline in Anaphylactic Shock

Understanding Anaphylaxis First

• Histamine, leukotrienes, prostaglandins, PAF → causing the clinical syndrome
• The result is a triad of: bronchospasm + vasodilation/hypotension + angioedema/urticaria

Why Adrenaline is the ONLY Drug That Tackles All Three Simultaneously

1. Alpha-1 Receptor Action → Reverses Vasodilation and Hypotension

• Anaphylaxis causes massive peripheral vasodilation and pooling of blood → severe hypotension and distributive shock
• Adrenaline's alpha-1 stimulation → vasoconstriction of arterioles and venules
• This raises systemic vascular resistance and restores blood pressure
• Also reduces urticaria and angioedema by constricting cutaneous and mucosal blood vessels, reducing vascular permeability and plasma leakage

2. Beta-2 Receptor Action → Reverses Bronchospasm

• Histamine and leukotrienes cause intense bronchospasm → life-threatening airway obstruction
• Adrenaline's beta-2 stimulation → bronchodilation, rapidly opening the airways
• Also reduces mucosal oedema and secretions in the airway
• Particularly critical in patients presenting with stridor or wheeze

3. Beta-1 Receptor Action → Reverses Cardiovascular Collapse

• Profound hypotension and vasodilation cause reflex and direct myocardial depression
• Beta-1 stimulation → positive inotropic and chronotropic effects → increases heart rate and cardiac output
• This directly combats the circulatory collapse component of anaphylactic shock

4. Inhibits Further Mediator Release (Mast Cell Stabilisation)

• Adrenaline raises intracellular cAMP in mast cells and basophils
• This suppresses further degranulation and release of histamine, leukotrienes, and other mediators
• This is a unique action - antihistamines only block histamine receptors AFTER release; adrenaline stops the release itself

Summary Table: Pathophysiology vs. Adrenaline's Action

Why No Other Drug Can Replace Adrenaline

"Epinephrine activates α, β1, and β2 receptors, all of which may be important in reversing the pathophysiologic processes underlying anaphylaxis."

• Katzung's Basic and Clinical Pharmacology, 16th Edition

"Epinephrine is the first-line treatment in patients with anaphylaxis and should be given immediately. There are no absolute contraindications to the use of epinephrine in the setting of anaphylaxis."

• Rosen's Emergency Medicine

Dose and Route

• Adults: 0.3-0.5 mg IM into the anterolateral thigh (1:1000 solution), repeated every 5-10 minutes as needed
• Children: 0.01 mg/kg IM (max 0.5 mg)
• IM preferred over SC because hypotension makes cutaneous absorption from SC injection unpredictable
• IV only in severe refractory cases with careful dilution (1:10,000) - higher risk of arrhythmias

Key Exam Point

• Katzung's Basic and Clinical Pharmacology, 16e, p. 2149
• Rosen's Emergency Medicine, pp. 211-217
• Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1420

Why Dopamine is Used in Cardiogenic Shock

First - What is Cardiogenic Shock?

↓ Cardiac contractility → ↓ Cardiac output → ↓ Tissue perfusion → Organ failure

• Hypotension (systolic BP < 90 mmHg)
• Low cardiac output (cold, clammy extremities, oliguria, altered sensorium)
• Elevated filling pressures (pulmonary congestion/oedema)
• Common causes: acute MI, severe heart failure, myocarditis, post-cardiac surgery

Dopamine's Mechanism - The Dose-Dependent Triple Action

🔵 Low Dose: 0.5-3 mcg/kg/min → Dopaminergic (DA1) receptors

• Dilates renal, splanchnic, and cerebral arteries
• Promotes diuresis and natriuresis
• In cardiogenic shock, this helps protect the kidneys from hypoperfusion injury
• (Note: "renal dose" dopamine has NOT been shown to improve kidney outcomes in clinical trials and is no longer routinely recommended for this purpose alone)

🟡 Moderate Dose: 3-10 mcg/kg/min → Beta-1 receptors ← The key dose for cardiogenic shock

Dopamine also acts indirectly at this dose by triggering norepinephrine release from presynaptic sympathetic nerve terminals, amplifying the adrenergic response.

🔴 High Dose: 10-20 mcg/kg/min → Alpha-1 receptors

• Causes peripheral vasoconstriction → raises vascular resistance and blood pressure
• Useful when hypotension is severe and unresponsive to moderate doses
• Risk: significantly increases afterload (resistance against which the failing heart must pump), which can worsen cardiac failure; also causes renal vasoconstriction, limb ischaemia, and arrhythmias

Summary of Rationale - Why Dopamine Works in Cardiogenic Shock

Important Clinical Caveat - Current Perspective

• Dopamine has more arrhythmias and higher mortality compared to norepinephrine in shock (this was a key finding from the SOAP II trial)
• In patients with advanced heart failure, dopamine's inotropic effect is unreliable because its mechanism depends partly on releasing norepinephrine from nerve terminals - and in chronic heart failure, these norepinephrine stores are already depleted (similar to tachyphylaxis with ephedrine)
• Dobutamine (pure beta-1 agonist) is now often preferred as the inotrope of choice when the main problem is low cardiac output with adequate BP
• Norepinephrine is preferred as the vasopressor when hypotension dominates

"Dopamine was formerly a first-line treatment for shock to improve cardiac output, support blood pressure, and maintain renal function. The chronotropic and proarrhythmic effects limit its usefulness, and it has been replaced by norepinephrine for many situations in critical illness."

• Morgan & Mikhail's Clinical Anaesthesiology, 7e

"Because the positive inotropic effect is largely dependent upon myocardial catecholamine stores, which are often depleted in patients with advanced heart failure, dopamine is a poor inotrope in patients with severe systolic dysfunction."

• Braunwald's Heart Disease, 2-Volume Set

Dopamine vs. Dobutamine in Cardiogenic Shock

• Morgan & Mikhail's Clinical Anaesthesiology, 7e, p. 452
• Braunwald's Heart Disease, pp. 183-186
• Tintinalli's Emergency Medicine, pp. 2947-2951
• Murray & Nadel's Textbook of Respiratory Medicine, p. 1565

Adverse Effects of Prazosin

1. First-Dose Phenomenon (Most Important / Characteristic ADR)

• What happens: A severe, precipitous drop in blood pressure (orthostatic hypotension) occurs shortly after the very first dose, which can cause syncope (fainting)
• Why it happens: The first dose causes sudden vasodilation of both arterioles and venules. The body's baroreceptor reflexes have not yet adapted to the new baseline. Venous pooling reduces venous return, dropping cardiac output, and the patient feels faint on standing
• When it's worst: More likely in patients who are salt/volume depleted (e.g., those on diuretics)
• How to prevent it:
  • Give the first dose at bedtime (patient is lying down, so BP drop is less dangerous)
  • Start with one-third or one-fourth of the normal dose
  • Warn the patient not to stand up suddenly after the first dose

2. Postural / Orthostatic Hypotension

• Persists to a milder degree even after the first-dose effect settles
• Dizziness and lightheadedness on standing up (especially in the morning)
• Due to alpha-1 blockade in venous capacitance vessels → venous pooling → reduced venous return
• Blood pressure is reduced more in the upright position than supine

3. Reflex Tachycardia and Palpitations

• Vasodilation → baroreceptor-mediated reflex sympathetic activation → increased heart rate
• However, reflex tachycardia with prazosin is much LESS than with non-selective alpha blockers (phentolamine, phenoxybenzamine)
• Reason: Prazosin blocks only alpha-1 (postsynaptic). The presynaptic alpha-2 receptors remain intact, so norepinephrine exerts negative feedback on its own release - limiting how much NE floods beta receptors to accelerate the heart

4. CNS Effects

• Dizziness (most common complaint)
• Headache
• Drowsiness / sedation / lassitude (lack of energy)
• Due to reduced cerebral perfusion pressure from vasodilation

5. Nasal Congestion (Nasal Stuffiness)

• Alpha-1 blockade in nasal mucosal blood vessels → vasodilation → mucosal swelling → blocked nose
• A common and bothersome side effect

6. Intraoperative Floppy Iris Syndrome (IFIS)

• A surgical adverse effect - important for ophthalmologists and surgeons
• Prazosin (and other alpha-1 blockers) cause the iris dilator muscle to lose tone
• During cataract surgery, the iris billows and flaps in response to irrigating fluid, making surgery technically difficult
• Patients on prazosin (or who have previously taken it) must inform their eye surgeon before any intraocular procedure

7. Salt and Water Retention (Oedema)

• Alpha-1 blockade → reduction in renal afferent arteriolar tone → reduced GFR stimulates aldosterone → sodium and water retention
• This blunts the antihypertensive effect over time if used without a diuretic
• Prazosin is therefore more effective when combined with a beta-blocker + diuretic

8. Sexual Dysfunction

• Retrograde ejaculation and impotence can occur
• Due to relaxation of smooth muscle in the urogenital tract (the same mechanism exploited therapeutically in BPH)

9. Drug Interactions Causing Excessive Hypotension

• PDE-5 inhibitors (sildenafil, tadalafil) + Prazosin → additive vasodilation → dangerous hypotension - this combination requires extreme caution
• Nitrates + Prazosin → additive vasodilatory effect → hypotension

10. Positive Antinuclear Factor (ANA)

• Some patients on chronic prazosin therapy develop a positive ANA test in serum
• This is a laboratory finding only - it has not been associated with clinical rheumatic symptoms or lupus-like syndrome
• Still worth monitoring

Summary Table

• Katzung's Basic and Clinical Pharmacology, 16e, pp. 3505-3509
• Lippincott Illustrated Reviews: Pharmacology, pp. 3502-3512

Papaverine / Phentolamine-Induced Penile Erection Therapy for Impotence

Background - The Physiology of Erection First

1. Parasympathetic + NANC nerves → release Nitric Oxide (NO)
2. NO activates guanylyl cyclase → ↑ cGMP in smooth muscle cells
3. cGMP activates protein kinases → K+ channels open, Ca²+ channels close, Ca²+ sequestered in endoplasmic reticulum
4. ↓ Intracellular Ca²+ → smooth muscle RELAXES
5. Relaxed cavernous sinusoids fill with blood → venous outflow compressed against tunica albuginea → erection

Molecular mechanism of penile smooth muscle relaxation - Campbell Walsh Wein Urology

What is Intracavernosal Injection Therapy?

Drug 1: Papaverine

What is Papaverine?

Mechanism of Action in Erection:

• Normally, PDE enzymes break down cAMP and cGMP inside smooth muscle cells
• Papaverine inhibits PDE → prevents breakdown of both cAMP and cGMP
• Both second messengers accumulate → ↓ intracellular Ca²+ → cavernous smooth muscle relaxation
• Sinusoidal spaces fill with blood → erection

Think of papaverine as "keeping the brakes off" - it doesn't trigger the relaxation signal, it just prevents the signal from being switched off

Additional Actions:

• Direct smooth muscle relaxant (independent of PDE inhibition)
• Relaxes both arteriolar smooth muscle (increases inflow) and cavernous sinusoidal smooth muscle (allows filling)

Drug 2: Phentolamine

What is Phentolamine?

Mechanism of Action in Erection:

• In the flaccid penis, norepinephrine acting on alpha-1 receptors keeps cavernous smooth muscle contracted → penis remains flaccid
• In ED, there is excessive adrenergic tone maintaining this contraction
• Phentolamine blocks alpha-1 receptors on cavernous smooth muscle → removes the norepinephrine-driven contraction → smooth muscle relaxes → sinusoids fill → erection
• It acts on the "anti-tumescence pathway" - by blocking the tonic constrictor signal (norepinephrine)

Harrison's 22e describes phentolamine as a "neutral-tone mediator" - it shifts the balance away from contraction toward relaxation

Why They Are Used TOGETHER (The Classic Combination)

Who Gets This Treatment?

• Men who fail oral PDE-5 inhibitors (sildenafil, tadalafil)
• Neurogenic ED (spinal cord injury, diabetic neuropathy, post-prostatectomy) - where the neural NO signal is absent; these drugs bypass the need for neural input entirely
• Vasculogenic ED (arterial or venous)
• Psychogenic ED unresponsive to other treatments

How It Is Administered

1. Patient (or partner) injects into the lateral aspect of the proximal third of the corpus cavernosum using a fine (27-30 gauge) needle
2. Avoids the urethra (midline), dorsal nerves and vessels (top), and superficial vessels
3. Erection begins in 5-15 minutes and lasts 30-60 minutes
4. Dose is titrated individually in the clinic first

Adverse Effects

Comparison with PDE-5 Inhibitors (e.g., Sildenafil)

• Campbell Walsh Wein Urology, 3-Volume Set, pp. 1865-1866
• Harrison's Principles of Internal Medicine, 22e, pp. 1622-1625
• Tintinalli's Emergency Medicine, p. 263
• Katzung's Basic and Clinical Pharmacology, 16e

Role of Tamsulosin in BPH (Benign Prostatic Hyperplasia)

Understanding BPH First - Why Is There Obstruction?

Alpha-1 Receptor Subtypes - The Key to Understanding Tamsulosin

Tamsulosin's Mechanism - "Uroselectivity"

• High affinity for alpha-1A and alpha-1D receptors (in prostate, bladder neck, urethra, detrusor)
• ~10-fold LESS affinity for alpha-1B (vascular) receptors

What Tamsulosin Does in the Prostate:

1. Blocks alpha-1A receptors on prostate smooth muscle → smooth muscle relaxes
2. The urethral lumen widens → reduced outlet resistance
3. Urine flows more easily → improved peak urinary flow rate (PFR)
4. Also blocks alpha-1D receptors in the bladder → reduces bladder overactivity and storage symptoms (urgency, frequency, nocturia)

Clinical Benefits in BPH

Voiding (Obstructive) Symptoms - relieved by reducing outlet resistance:

• Weak stream / poor flow
• Hesitancy (difficulty starting urination)
• Straining
• Incomplete bladder emptying
• Terminal dribbling

Storage (Irritative) Symptoms - relieved via alpha-1D blockade in bladder:

• Urgency
• Frequency
• Nocturia (one of the most QoL-impacting symptoms - significantly reduced by tamsulosin)

• Tamsulosin 0.4 mg/day → mean decrease of 8.3 points in AUA Symptom Index (vs. 5.5 for placebo)
• Peak urinary flow rate improved by 1.75 mL/s vs. 0.5 mL/s for placebo
• Onset of action: PFR increases within 4-8 hours of the first dose; symptom relief evident within 1 week

Why Tamsulosin is Preferred Over Older Alpha Blockers

"Mean changes in systolic and diastolic blood pressure did not differ between placebo and tamsulosin in both hypertensive and normotensive patients."

• Campbell Walsh Wein Urology

Dose and Administration

• Standard dose: 0.4 mg once daily, taken 30 minutes after the same meal each day
• Can be increased to 0.8 mg if response is inadequate (higher symptom score reduction but more side effects)
• No titration needed (unlike prazosin/doxazosin)

Adverse Effects of Tamsulosin

Tamsulosin's Place in BPH Management

BPH Symptoms
    │
    ├── Mild symptoms → Watchful waiting + lifestyle changes
    │
    ├── Moderate symptoms → Alpha-1 blocker (Tamsulosin 0.4 mg)
    │                       ↓ Fast onset (days-weeks)
    │
    ├── Large prostate (>30-40g) + moderate-severe symptoms
    │   → Tamsulosin + 5α-reductase inhibitor (finasteride/dutasteride)
    │     [Combination therapy - CombAT trial]
    │
    └── Failed medical therapy → Surgery (TURP)

• Campbell Walsh Wein Urology, 3-Volume Set, pp. 502-541
• Lippincott Illustrated Reviews: Pharmacology, pp. 698-700
• National Kidney Foundation Primer on Kidney Diseases, 8e, p. 1900